Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2021

01-07-2021 | Original Research

Health Literacy, Processing Capacity, Illness Knowledge, and Actionable Memory for Medication Taking in Type 2 Diabetes: Cross-Sectional Analysis

Authors: Jessie Chin, Ph. D., Huaping Wang, Ph. D., Adam W. Awwad, MS., James F. Graumlich, M.D., Michael S. Wolf, Ph.D., Daniel G. Morrow, Ph. D.

Published in: Journal of General Internal Medicine | Issue 7/2021

Login to get access

Abstract

Background

Patient knowledge about the purpose of medications is crucial to ensure safe and correct use, so it is an important index of adherence in patients with chronic illness.

Objective

We examined how health literacy and its components (processing capacity and knowledge about illness) influence memory for medication purposes.

Design

We conducted a cross-sectional study to examine memory for medication purposes in relation to health literacy, processing capacity, and illness knowledge among patients with diabetes in outpatient clinics.

Participants

Six hundred seventy-four adults who were diagnosed with type II diabetes mellitus, age 40 years or older, taking 5 or more current medications, native speakers of English, and with glycosylated hemoglobin (HbA1c) of 6.0 or more, were recruited to the study.

Main Measures

We included measures of processing capacity, illness knowledge, health literacy, and actionable memory for medication taking (memory for medication purpose).

Key Results

Results suggested an association between health literacy and both processing capacity and health knowledge, with some evidence that knowledge can compensate for limited processing capacity in order to maintain health literacy. Furthermore, health literacy was associated with memory for medication purposes, with processing capacity and health knowledge partly mediating this association. This pattern of results supports the process-knowledge model of health literacy.

Conclusions

Our findings establish the role of health literacy in medication taking, in relation to broader cognitive abilities and knowledge. Implications for improving the learning of medication purpose among diverse older adults with chronic illness are discussed.

Trial Registration

NIH trial registry number: NCT01296633
Literature
24.
go back to reference Fillenbaum GG. Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Psychology Press. 1988. Fillenbaum GG. Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Psychology Press. 1988.
25.
go back to reference Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25(6):391-395.PubMed Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25(6):391-395.PubMed
28.
go back to reference Cohen J. Statistical Power Analysis for the Behavioral Sciences. Routledge. 2013. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Routledge. 2013.
36.
go back to reference Kintsch W. Comprehension: A Paradigm for Cognition. Cambridge University Press. 1998. Kintsch W. Comprehension: A Paradigm for Cognition. Cambridge University Press. 1998.
Metadata
Title
Health Literacy, Processing Capacity, Illness Knowledge, and Actionable Memory for Medication Taking in Type 2 Diabetes: Cross-Sectional Analysis
Authors
Jessie Chin, Ph. D.
Huaping Wang, Ph. D.
Adam W. Awwad, MS.
James F. Graumlich, M.D.
Michael S. Wolf, Ph.D.
Daniel G. Morrow, Ph. D.
Publication date
01-07-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06472-z

Other articles of this Issue 7/2021

Journal of General Internal Medicine 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine